MA
DXCM icon

Montag & Associates’s DexCom DXCM Stock Holding History

Montag & Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42
Closed -$2.83K – 1022
2025
Q3 		$2.83K Buy
+42
New +$3.32K ﹤0.01% 878
2024
Q3 		– Sell
-650
Closed -$73.7K – 1036
2024
Q2 		$73.7K Buy
650
+95
+17% +$12K ﹤0.01% 533
2024
Q1 		$77K Sell
555
-60
-10% -$7.54K ﹤0.01% 528
2023
Q4 		$76.3K Sell
615
-4,041
-87% -$413K ﹤0.01% 505
2023
Q3 		$434K Buy
4,656
+653
+16% +$73.6K 0.03% 302
2023
Q2 		$514K Buy
4,003
+173
+5% +$20.9K 0.03% 282
2023
Q1 		$445K Sell
3,830
-544
-12% -$60.9K 0.03% 293
2022
Q4 		$495K Buy
4,374
+766
+21% +$84.1K 0.03% 262
2022
Q3 		$291K Sell
3,608
-3,336
-48% -$283K 0.02% 320
2022
Q2 		$518K Sell
6,944
-38,284
-85% -$3.49M 0.03% 261
2022
Q1 		$5.79M Buy
45,228
+544
+1% +$59.5K 0.31% 94
2021
Q4 		$6M Buy
44,684
+996
+2% +$143K 0.3% 95
2021
Q3 		$5.97M Buy
+43,688
New +$5.51M 0.32% 87
2021
Q1 		– Sell
-256
Closed -$24K – 868
2020
Q4 		$24K Buy
+256
New +$22.9K ﹤0.01% 620

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Montag & Associates's DXCM Position: Q4 2025 in Review

Montag & Associates sold out of DexCom (DXCM) in Q4 2025, closing a stake of 42 shares — an estimated $2.83K sold.

Montag & Associates first reported a position in DXCM in Q4 2020 and held it in 14 quarters. The position peaked at $6M in Q4 2021. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Montag & Associates reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Montag & Associates sold 42 DexCom shares in Q4 2025, an estimated $2.83K.
  • Montag & Associates first reported a position in DexCom in Q4 2020 and held it in 14 quarters.
  • Montag & Associates's DexCom position peaked at $6M in Q4 2021.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.